About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 429 record(s)
Req # A-2023-000869
Adverse Drug Reactions (ADRs). Report numbers: 001032877, 001034437, 001034838, 001038896, 001042304, 001035863, 001038090, 001039491, 001042722.Organization: Health Canada
October 2023
Req # A-2023-000882
Adverse Drug Reaction (ADR). Report number: 001039714.Organization: Health Canada
October 2023
Req # A-2023-000898
Adverse Drug Reactions (ADRs) for BENADRYL. Report numbers: 001025260, 001050026. ADRs for REACTINE. Report numbers: 001020501, 001032539. ADRs for TYLENOL. Report numbers: 001015816, 001021323, 001021598, 001025911. ADR for BENZOCAINE. Report…Organization: Health Canada
October 2023
Req # A-2023-000899
Adverse Drug Reactions (ADRs) for ACETAMINOPHEN. Report numbers: 001029707, 001035137, 001037832.Organization: Health Canada
October 2023
Req # A-2023-000902
Adverse Drug Reactions (ADRs) for MOTRIN. Report numbers: 001048236, 001048837, 001049292, 001049949, 001049969, 001050122.Organization: Health Canada
October 2023
Req # A-2023-000904
Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001013761, 001015268, 001018555, 001022658, 001023661, 001023706, 001028874, 001031987, 001038200, 001039630.Organization: Health Canada
October 2023
Req # A-2023-000906
Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001043002, 001047381, 001049982.Organization: Health Canada
October 2023
Req # 2340-609
"Complaints regarding the closure of Jacques Cartier Bridge due to festivals, maintenance and/or construction” •July 2022 to July 2023 •A table and/or list of reports "Organization: Jacques Cartier and Champlain Bridges Incorporated
October 2023
Req # A-2022-00015
For each application to the 2021-2022 Grant Program of Discovery Research, under the Research Subject of “Biochemistry”, I am requesting: (1) Merit indicator/selection criterion ratings by the Evaluation Group, (2) any Evaluation Group written…Organization: Natural Sciences and Engineering Research Council of Canada
October 2023
Req # A-2022-00016
For each application to the 2021-2022 Grant Program of Discovery Research, under the Research Subject of “Nuclear engineering”, I am requesting: (1) Merit indicator/selection criterion ratings by the Evaluation Group, (2) External reviewer reports…Organization: Natural Sciences and Engineering Research Council of Canada
October 2023